Minerva Neurosciences Inc

Stocks Under $10 Biotech Stocks Healthcare Stocks

$6.09

+0.07 (+1.08%)

As of Apr 1, 2:35 PM ET ·

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 4 57%

Sell 3 43%

Price Target

Analyst Price Target -33.8% upside

Low Target $3.03

Average Target $4.03

High Target $5.66

Current Price $6.09

Current
$6.09

Target
$4.03

$3.03 $4.03 avg $5.66

Scenario Analysis

Bear Case

$3.03

-50.2%

Low target

Base Case

$4.03

-33.8%

Avg target

Bull Case

$5.66

+-7.1%

High target

Risk/Reward

0.1x

Unfavorable

Price in Context

52-Week High

$5.30

14.9% from high

52-Week Low

$2.69

+126.4% from low

Target vs 52W High

$4.03

-24.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+19.8%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.0%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+158.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-13.0%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-29.7%